Bioscience

Barrow researchers receive more than $2M in NIH grants

January 21, 2010

By Flinn Foundation

[Source: BNI] – Four scientists at Barrow Neurological Institute at St. Joseph’s Hospital and Medical Center have been awarded more than $2.2 million from the National Institutes of Health (NIH) to research the effects of nicotine and develop new tobacco-related drug therapies.

The grants will fund three separate research projects at the Phoenix-based institute in the next several years.  Ronald J. Lukas, PhD and Vice President of Research at Barrow, is one of the world’s leading experts on nicotine and has spent much of his research career studying its impact.  Lukas’ research lab, shared by Paul Whiteaker, PhD, is the main recipient of the funding.  The Barrow laboratories of Jie Wu, MD, PhD, and Yongchang Chang, MD, PhD, also will receive funding from the grants.

For more information: Barrow Researchers Receive More Than $2 Million In NIH Grants for Nicotine Studies